Forte Biosciences, Inc.

FBRX · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $0.6B · 19 employees
165
SEC Filings
$76.99
Close 2026-08-26
19
Employees

Business Summary

Forte Biosciences, Inc. is a clinical-stage biopharmaceutical company developing FB102, a proprietary anti-CD122 monoclonal antibody targeting autoimmune and autoimmune-related diseases. FB102 inhibits IL-2/IL-15 receptor signaling to suppress NK cells and certain T cell subsets while sparing regulatory T cells. The company is conducting Phase 1b trials in celiac disease and non-segmental vitiligo, and a Phase 1b study in alopecia areata, with a Phase 2 celiac study initiated in July 2025.

Latest Stock Quote

FBRX 2026-08-26 $76.99 O:$76.97 H:$77 L:$76.96 Vol:1.4M VWAP:$76.9834
origin leaf: null

Next Earnings

expected 2026-11-26

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-312025-12-310001193125-26-134498EDGAR70K words
2025-03-282024-12-310000950170-25-046749EDGAR71K words
2024-03-182023-12-310000950170-24-032843EDGAR68K words
2023-03-312022-12-310000950170-23-011355EDGAR—
2022-03-312021-12-310001564590-22-012987EDGAR—
2021-03-162020-12-310001564590-21-013249EDGAR—
2020-02-272019-12-310001564590-20-007402EDGAR—
2019-02-272018-12-310001564590-19-004933EDGAR—
2018-03-092017-12-310001564590-18-005132EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-08-122026-06-300001193125-26-346787EDGAR55K words
2025-11-142025-09-300001193125-25-281808EDGAR53K words
2025-08-142025-06-300000950170-25-108889EDGAR53K words
2025-05-152025-03-310000950170-25-072569EDGAR50K words
2024-11-142024-09-300000950170-24-127031EDGAR53K words
2024-08-142024-06-300000950170-24-096988EDGAR52K words
2024-05-132024-03-310000950170-24-058669EDGAR51K words
2023-11-132023-09-300000950170-23-062907EDGAR52K words
2023-08-142023-06-300000950170-23-042518EDGAR49K words
2023-05-152023-03-310000950170-23-022184EDGAR44K words
2022-11-142022-09-300000950170-22-024977EDGAR—
2022-08-152022-06-300000950170-22-017378EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-08-270001140361-26-034698EDGAR7K words
2026-07-270001193125-26-316766EDGAR2K words
2026-04-010001193125-26-135767EDGAR2K words
2025-11-140001193125-25-281807EDGAR2K words
2025-08-140001193125-25-180771EDGAR2K words
2025-06-250001193125-25-147017EDGAR1K words
2025-06-230001193125-25-144174EDGAR4K words
2025-05-300001193125-25-131525EDGAR1K words
2025-05-150001193125-25-120772EDGAR2K words
2025-04-180001193125-25-085762EDGAR1K words

165 total filings indexed. 134 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACIU — AC Immune SA ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA

Tags

celiac-disease vitiligo alopecia-areata type-1-diabetes autoimmune-diseases good-laboratory-practice-(glp) good-clinical-practice-(gcp) current-good-manufacturing-practice-(cgmp) biologic-license-application-(bla)

Company Identity

CIK0001419041
TickerFBRX
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE
Websitehttps://www.fortebiorx.com
Listed2020-06-16

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: ff8c7f0f5789103f183dfc7bd83c77fce073e9549f047a5b98f415f9824e523d
parent: 17b0f8766a6e2cd4b1f1db5cb0a144c700eb65f79c6c4bbce43d2a02abab8a97
content hash: 3b6d979c7970c993366835cab4750ed8f7eede0fcf6ac3e7c0475354a14c7b51
signed: 2026-09-28T19:01:13.733Z
sources: 21 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up FBRX using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on FBRX, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/FBRX (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.